SPEAKERS

October 27-28, 2015
Santa Clara Convention Center


Keynote

Evolving State of HealthTech


Anne DeGheest

Founder, Managing Director HealthTech Capital

Anne has 25 years investing and mentoring experience with MedStars, and has been a pioneer entrepreneur and investor in the emerging HealthTech sector. Companies in which Anne has been involved have been market changers and have grown to $6 billion market cap. She has startup operating experience as CEO and VP as well as public and private board positions. Anne earned a Master in Business Engineering, Brussels and an MBA, Harvard.


Panel

Serial entrepreneurs: secrets to success


Glen Tullman

Chairman and Chief Executive Officer, Livongo Health

Glen Tullman is Chairman and Chief Executive Officer of Livongo Health™. Tullman is also a successful entrepreneur and co-founder and Managing Partner of 7wire Ventures, a Chicago-based investment firm focused on healthcare and education. Tullman most recently served as Chief Executive Officer of Allscripts (NASDAQ: MDRX), the leading global provider of Electronic Health Records, Practice Management and Electronic Prescribing systems. He led Allscripts’ IPO and secondary offerings. Under his leadership, revenues grew from $30 million in 1997 to more than $1.4 billion in 2012. Tullman stepped down in December 2012.

Prior to joining Allscripts, Tullman was CEO of Enterprise Systems, a leading healthcare-information services company providing resource-management solutions to large, integrated healthcare networks. Tullman led its IPO and secondary offerings. Enterprise was sold to McKesson HBOC (NYSE: MCK).

Tullman has founded or co-founded a number of ventures including one of the country’s leading solar energy companies, SoCore Energy, recently sold to Edison Ventures, and a digital education company, digedu, and holds investments in several ventures focused on mobile and cloud-based health solutions. A strong proponent of philanthropy, he serves as a Chancellor to the International Board of the Juvenile Diabetes Research Foundation (JDRF).

Read full bio →


Jeffrey H. Margolis

Margolis Enterprises, LLC
Chairman and CEO, Welltok, Inc.
Founding CEO and Chairman Emeritus, TriZetto

Jeff Margolis is widely recognized as a healthcare IT entrepreneur and innovator based on his 30-year track record of successfully applying technologies to address the complex problems facing the healthcare industry. Leveraging his deep systematic understanding of healthcare and groundbreaking architectural and integration methodologies, Jeff has built some of the nation’s largest and most innovative healthcare technology and service organizations.

Jeff is currently Chairman and CEO of Welltok, Inc., where he is driving the transformation of our current sickcare system to one of optimized health. Prior to Welltok, Jeff founded TriZetto, the first industry vertical SaaS enterprise solution, and originated the concept of Integrated Healthcare Management. During his tenure as Chairman and CEO, Jeff led TriZetto through a successful IPO and $1.4B private equity buyout.

Jeff currently serves as a member of the board of directors for Quality Systems, Inc. (NASDAQ:QSII), Predilytics and Alignment Healthcare. Jeff also serves the national and local communities on the boards of several prominent non-profit and for profit organizations, including the Crohn’s & Colitis Foundation of America, Hoag Hospital in Newport Beach and the University of California at Irvine Center for Health Care Management & Policy. As a health futurist and visionary, Jeff is a frequent speaker, guest lecturer and author of two books, including The Healthcare Cure. Jeff is an alumnus of the University of Illinois and holds certified public accountant certificates in Colorado and Illinois.

Read full bio →

Panel

What are the unmet needs of Providers?


Amir Dan Rubin

President & CEO, Stanford Health Care

Amir Dan Rubin serves as President and CEO of Stanford Health Care, which seeks to serve humanity through science and compassion, one patient at a time, through its commitment to care, educate, and discover. With an operating budget of $2.7 Billion and an affiliation with Stanford University, Stanford Health Care provides leading edge and coordinated care across its growing healthcare system.

APrior to Stanford, Amir served as Chief Operating Officer for the UCLA Health System, responsible for the operations of the Ronald Reagan UCLA Medical Center, Mattel Children's Hospital at UCLA, the Resnick Neuropsychiatric Hospital at UCLA, Santa Monica-UCLA Medical Center and Orthopedic Hospital, and an array of outpatient centers across the west side of Los Angeles. Prior to UCLA, Amir has served as Chief Operating Officer for Stony Brook University Hospital in New York, as Assistant Vice President of Operations for Memorial Hermann Hospital in Texas, and as Director of Business Development for Memorial Hermann Healthcare System in Texas. Amir also previously worked as a healthcare management consultant with APM in San Francisco.

Amir currently serves on the board of directors of the University HealthSystem Consortium (UHC), the American Association of Medical College’s (AAMC’s) Council of Teaching Hospitals (COTH), the National Center for Healthcare Leadership, and The Joint Commission’s Leadership Advisory Council. He has been a frequent guest lecturer and presenter on health care strategy, lean operations, and customer service at Stanford’s Graduate School of Business and School of Medicine, UCLA’s Graduate Schools of Business and Public Health, and many other organizations.

Amir earned a Master’s degree in Business Administration and a Master’s degree in Health Services Administration from the University of Michigan, and a Bachelor’s degree in Economics with a minor in Business Administration from the University of California, Berkeley.

Read full bio →


Rich Roth

Chief Strategic Innovation Officer, Dignity Health

Rich Roth leads Dignity Health's innovation efforts, which seek to create and test novel services, programs, partnerships, and/or technologies – from within and outside of healthcare – that challenge the status quo and have the potential to reduce the cost of care, improve quality, and/or increase access to services. Working in concert with Dignity Health employees and physicians, Roth works to anticipate emerging trends and technologies with the goal of incubating, studying, and scaling efforts to improve care. Dignity Health's current focus is in the areas of mobile care and sensor based technology. Roth holds a Master's degree in Healthcare Administration from the University of Minnesota and a Bachelors degree in Public Health from West Chester University. He regularly advises venture capital organizations, and is on the Board of Ascension Health Ventures. In 2012, he was recognized by CHAUSA as one of the most promising leaders under 40 in healthcare.



Thomas Thornton

Senior Vice President, North Shore Ventures, North Shore-LIJ Health System

Tom is responsible for identifying and fostering innovative ideas that enhance the growth of NSLIJ’s clinical and non-clinical enterprises, working with senior leadership to develop and advance ideas in these areas, bringing these ideas into practice and the market, as well as building strategic partnerships and relationships within the broader regional ecosystem and beyond. In this role, he manages all the North Shore-LIJ’s innovation programs; including technology commercialization, enterprise growth and investment management.

Prior to joining North Shore-LIJ, Tom led the Healthcare Innovation Alliance at Cleveland Clinic Innovations; a program aimed at forming multi-institutional collaborations to foster and accelerate the commercialization of medical innovations.



Molly Coye

Social Entrepreneur in Residence Network for Excellence in Health Innovation/NEHI

Dr. Molly Joel Coye is Social Entrepreneur in Residence for the Network for Excellence in Health Innovation (NEHI), a nonprofit national health policy institute focused on enabling innovations that provide solutions to the most pressing issues facing our health care system today. From 2010 – 2015, Dr. Coye was the Chief Innovation Officer for UCLA Health and headed the Institute for Innovation in Health and the Global Lab for Innovation at UCLA, where she led the health system in identifying new strategies, technologies, products and services to support the large-scale transformation of healthcare. Today the Global Lab for Innovation advances the exchange of health delivery innovations that enable dramatic improvements in access to and affordability of health services. Dr. Coye also advises technology developers, investors, national health systems and policy makers about disruptive technologies and business models that accelerate transformation and constrain health expenditures.

Dr. Coye was previously the founder and CEO of the Health Technology Center (HealthTech), a non-profit education and research organization established in 2000 that became the premier forecasting organization for emerging technologies in health care. Dr. Coye has also served as Commissioner of Health for the State of New Jersey, Director of the California State Department of Health Services, and Head of the Division of Public Health Practice at the Johns Hopkins School of Hygiene and Public Health. Dr. Coye is an elected member of the Institute of Medicine, and a member of the Board of Directors of Aetna, Inc., Prosetta Biosciences, Inc., Big White Wall, and ACCESS Health International. She has previously served as Chair of the Board of Directors of PATH, one of the largest nonprofit organizations in global health, and on the boards of the American Hospital Association, the American Public Health Association, the American Telemedicine Association, Cholestech, Inc., The California Endowment, and the China Medical Board, as well as the advisory boards of venture and private equity firms investing in healthcare information technology and services. Dr. Coye holds M.D. and M.P.H. degrees from Johns Hopkins University and an MA in Chinese History from Stanford University, and is the author of two books on China.

Read full bio →

Panel

How are Employers driving healthcare changes?


Kyu Rhee, MD, MPP

Chief Health Officer and Vice President, IBM Corporation

Dr. Rhee serves as Chief Health Officer and Vice President of IBM, where he has direct global responsibilities for all IBM integrated health services strategy, design and operations, which include key support and leadership of business development and corporate citizenship opportunities in health and healthcare. Prior to joining IBM, Dr. Rhee was Chief Public Health Officer at the Health Resources and Services Administration (HRSA), which is the primary federal agency for improving access to health care services for people who are uninsured, isolated, or medically vulnerable. While at HRSA, he served on and led numerous national initiatives related to prevention, quality, and public health. Dr. Rhee also served as the Director of the Office of Innovation and Program Coordination at the National Institutes of Health (NIH), which is the primary federal agency for research. While at NIH, he served on and led numerous initiatives related to eliminating health disparities and promoting health equity.

Prior to his federal government service, he worked in community health settings as the Chief Medical Officer of Baltimore Medical System Inc., the largest network of Federally Qualified Health Centers in Maryland. In addition, Dr. Rhee served five years as a National Health Service Corps Scholar and Medical Director at Upper Cardozo Health Center, the largest community health center in Washington, DC. During that time, he taught at the George Washington University School of Public Health, where he received a “Best Teacher” award for his class in Community Health Leadership.

Dr. Rhee received double-board certification in both internal medicine and pediatrics. He obtained his medical degree from the University of Southern California. He did his residency and served as a Chief Resident in internal medicine and pediatrics at Cedars-Sinai Medical Center in Los Angeles. Dr. Rhee also holds a master's degree in public policy from the John F. Kennedy School of Government, Harvard University with a concentration in Health Care Policy. He acquired his bachelor's degree from Yale University in Molecular Biophysics and Biochemistry, where he also served as President of the study body.

In addition to his service on various public and private sector committees and boards, including those sponsored by the Institute of Medicine, Agency for Healthcare Research and Quality, the Robert Wood Johnson Foundation, the Clinton Foundation, the National Quality Forum, and the National Business Group on Health, Dr. Rhee speaks frequently and has published in numerous peer-reviewed journals, including American Family Physician, Pediatric Annals, Journal of Health Care for the Poor and Underserved, and the American Journal of Public Health.

Read full bio →


Derek Newell

CEO, Jiff, Inc.

For 20 years, Derek has been leading innovative health technology and service companies. He led the company that built the first FDA-approved internet connected medical device and grew it into the world’s largest remote patient monitoring company. Before that, at LifeMasters, he helped pioneer the first patient-centric disease management platform and built one of the largest disease management companies in the US. Derek holds graduate degrees in business and public health from UC Berkeley.



Lawrence "Rusty" Hofmann, MD

Co-Founder, Grand Rounds
Professor and Chief, Interventional Radiology, Stanford University

Dr. Rusty Hofmann, from Stanford Health, co-founded Grand Rounds with the goal of ensuring access to state-of-the-art care to everyone, everywhere. A few years ago, his son, Grady, became extremely ill and almost died. Dr. Hofmann was able to get an expert opinion from the country’s leading pediatric gastroenterologists on Grady’s diagnosis and treatment, which ultimately saved his life. With his “insider status,” Dr. Hofmann had access to the world’s greatest medical minds. Founded in 2011, Grand Rounds was born out of Dr. Hofmann’s vision to make all health care consumers “medical insiders.” The Grand Rounds solution helps restore individual health and quality of life, and benefits employers by facilitating decreased health care cost and increased employee productivity.

Through an employer health benefit, Grand Rounds pairs patients with the physicians experts most uniquely qualified to help them, nationally and/or locally. Chiefs, chairs and clinical experts from 115 leading institutions are available for remote patient access on the Grand Rounds platform. Of the roughly 770,000 active U.S. physicians, 96 percent have been rated by the Grand Rounds quality algorithm to help guide patients to top-quality local care. With coverage in more than 120 countries, over 50 leading companies are putting Grand Rounds’ expertise and technology to work in granting their employees an all-access pass to the best in American medicine.

Read full bio →

Panel

Is digital Mental Health finally here?


Ravi Hariprasad, MD, MPH

Head of Clinical Programs, Ginger.io

Dr. Hariprasad currently leads the strategy and development of Ginger.io’s clinical programs, applying the advanced technology platform to the frontlines of clinical deployment. He is an experienced psychiatrist and innovator with background in the practice of medicine, engineering and clinical research. Prior to joining Ginger.io, he served as a clinical leader at Kaiser Permanente and launched two successful companies in mobile technology and data security software. Dr. Hariprasad received his M.D. from the University of Pennsylvania and his B.S. in Operations Research Engineering from Cornell University. He completed both his residency training and received his M.P.H from Harvard University (Massachusetts General Hospital). Dr. Hariprasad has also complemented his formal training with studies in the traditional sciences of Vedic wellness and Ayurvedic medicine.



Eve Phillips

CEO, Empower Interactive, Inc.

Eve is the CEO & Co-Founder of Empower Interactive, Inc., a leader in digital behavioral health solutions. She is an experienced Silicon Valley product builder, entrepreneur and investor with expertise in assembling diverse teams to solve hard problems. Eve started her career as a product manager at Trilogy, an enterprise e-commerce software company, working on new ventures. From there, Eve held product, strategy and business development roles in software and internet businesses including Microsoft, Zazzle and eCert. Eve has also been a member of the investment teams at Amadeus Capital Partners, Vector Capital, and Greylock Partners. Prior to co-founding Empower, Eve was a Research Affiliate in the Synthetic Neurobiology Group at the MIT Media Lab. Eve holds an MBA from Stanford University and an SB and an M.Eng in Computer Science from the Massachusetts Institute of Technology.



Seth Feuerstein

Chief Innovation Officer, Magellan Health

Seth Feuerstein is a psychiatrist, entrepreneur and technology executive responsible for driving technology innovation within Magellan’s computerized cognitive behavioral therapy platform and programs. This portfolio is the leading behavioral change and engagement software suite used by millions of individuals throughout the U.S., U.K. and other health systems. Awarded the TripleTree iAward for Connected Health in the area of “Clinical Effectiveness,” this software was developed by Feuerstein’s team at Cobalt Therapeutics, a company he started and where he served as CEO until the company was acquired by Magellan in 2014.

He also uses information technology in community service areas and founded a non-profit called Little Wonder, which improves the daily experience of cancer patients in treatment and helps patients and their loved ones create meaningful, powerful experiences together. His program has won several awards and has rapidly expanded to now serve 20 cancer centers.

He holds medical and law degrees from New York University and completed his clinical training in psychiatry at the Yale University School of Medicine in New Haven, Conn., where he is a member of the clinical faculty.

Read full bio →


Alon Matas

Founder, BetterHelp

Alon Matas founded BetterHelp, the world's largest e-counseling platform. With BetterHelp, anyone facing life's challenges can have an easy, affordable, and private access to a licensed and certified therapist. BetterHelp's members get professional counseling using their computer, tablet or mobile phone, anytime they need, anywhere they are. In 2015 BetterHelp was acquired by Teladoc (NYSE: TDOC), the nation's first and largest telehealth provider.

Prior to BetterHelp, Alon was the Founder and CEO of three startups in the consumer web space, leading them through their entire life cycles: conceptualizing, planning, fundraising, team building, product design, development, launch, iteration, commercialization, optimization, growth, and eventually M&A.

Alon is an advocate, advisor and mentor for ventures and ideas that use tech-based innovations to improve quality of life.


Panel

How will Value Based Care change healthcare delivery?


David Sayen

Regional administrator, Centers for Medicare & Medicaid Services

David Sayen assumed the position of Regional Administrator of the Centers for Medicare & Medicaid Services, Region IX in February 2008. David is based in San Francisco, and his jurisdiction includes California, Arizona, Nevada, Hawaii, and the Pacific Territories. He replaces Acting Regional Administrator Charlotte Yeh, who is returning to her regular duties as Regional Administrator of the New England region of CMS.

David brings more than 29 years of Federal service and experience in health and human services programs to the position of Regional Administrator. Since 2002, he has served as Associate Regional Administrator for the Division of Medicare Health Plans Operations, leading all private health plan contract operations for Medicare Advantage and the Medicare Prescription Drug benefit in Region IX. From 1999 to 2002, he was the Associate Regional Administrator for the Division of Medicare Financial Management, where he ran the Medicare Contractor Financial Management and Program Integrity functions.

From 1998 to 1999, David led a team charged with ensuring that 11 Medicare claims processors successfully prepared for Y2K. From 1994 to 1998, he directed all Medicare managed care and fee-for-service customer service operations as Branch Chief, Medicare Managed Care Branch, in the Philadelphia Regional Office of CMS.

In 2003 David was named a Senior Fellow of the Council on Excellence in Government Fellowship, and he is also a member of the Adaptive Business Leaders Healthcare Roundtable of Northern California. He earned a bachelor’s degree in philosophy from Temple University, Philadelphia, PA in 1977 and an MBA with an emphasis on health administration from Temple University in 1991.

David lives with his family in Alameda, CA.

Read full bio →


Jeffrey Rideout, M.D., M.A., FACP

President and CEO, the Integrated Healthcare Association
Senior Advisor, GE Ventures
Consulting Professor, Stanford University, Health Research and Policy
Lecturer, University of California Berkeley, Haas School of Business

Dr. Rideout was recently appointed as President and CEO of the Integrated Healthcare Association. The Integrated Healthcare Association is a California statewide multi-stakeholder leadership group that promotes quality improvement, accountability and affordability of health care. Dr. Rideout also serves as a Senior Advisor to GE Ventures, focusing on new business development related to Digital Health and Digital Therapeutics, including assessing and accelerating new early stage solutions and companies. Dr. Rideout holds academic appointments with Stanford University and University of California Berkeley Haas School of Business, teaching on topics related to healthcare technology, services and investment.

Previously Dr. Rideout served as the Senior Medical Advisor for Covered California, the state based insurance exchange for California. Together with Medi-Cal expansion, the state of California reduced the number of uninsured in California by 50% in its first year. In this role Dr. Rideout was responsible for quality and network management and all physician and hospital relations. Previously Dr. Rideout was SVP, Chief Medical Officer for The TriZetto Group, leading strategy around development and delivery of a comprehensive suite of products and services that enable payers, providers and employers improve the cost and quality of care for consumers. Dr. Rideout also served as the global leader of the healthcare division for Cisco Systems Internet Business Solutions Group, and Cisco’s Chief Medical Officer, working with health care and public sector leaders to help them use technology to accelerate transformation of the health care industry, and also provided strategic leadership for health benefit value purchasing decisions for Cisco’s 65,000 employees and dependents worldwide. While at Cisco, Dr. Rideout also served as a member of the American Health Information Community (AHIC’s) Chronic Care Workgroup for the US Department of Health and Human Services.

Prior to Cisco, Dr. Rideout was Chief Medical Officer and SVP for Blue Shield of California and head of Quality Management for Blue Cross of California/WellPoint. Dr. Rideout served as a member of the National Advisory Council for the Robert Wood Johnson/IHI Pursuing Perfection grant program for excellence in health care delivery, and also served as the Chief Medical Officer for the National Health Care Purchasing Institute. Dr. Rideout is currently on the board of Contra Costa Interfaith Housing, which provides permanent housing to low income families in the Contra Costa County in California.

Dr. Rideout completed his residency training in internal medicine at University of California, San Francisco and is a Fellow of the American College of Physicians. He received his medical degree from Harvard Medical School and his undergraduate degree from Stanford University. He also holds a master’s degree in Philosophy, Politics, and Economics from Oxford University where he studied as a Rhodes Scholar.

Read full bio →


Sam Glick

Partner, Oliver Wyman

Sam Glick is a Partner in Oliver Wyman’s Health and Life Sciences practice, and the San Francisco Office Leader. He focuses on consumer-centric healthcare, working with leading providers, health plans, employers, enablement companies, retailers, and venture capital firms to find innovative, engaging ways to bend trend. He is an author of several recent Oliver Wyman points of view, including A Billion-Dollar Decision: Charting a New Course for US Healthcare Benefits and Private Exchanges Change the Game. Sam also leads many of Oliver Wyman’s healthcare commercialization research and intellectual capital development efforts.

Sam has been invited to speak at a number of events for healthcare senior executives and board members, including the American Hospital Association (AHA) Leadership Summit, the AHA Center for Healthcare Governance Symposium, the Council on Employee Benefits Annual Conference, the Accountable Care Congress, the Integrated Healthcare Association annual board retreat, the CAPG Healthcare Conference, the Leadership Institute roundtable, and the UnitedHealth Group Smart Circle series. He is quoted regularly in both the industry and popular press.

Previously, Sam was in the high-tech strategy practice at Accenture. Prior to that, he led global business strategy, new offer development, merger, acquisition, and divestiture activities at Mercer. He also spent six years as the founder and chief executive of Algebra Online, a web-based educational services business.

Sam received his BA with honors in economics from Pomona College, and was a Rotary Ambassadorial Scholar and North American Postgraduate Scholar in the MSc program in economics at the University of Warwick. He chairs the Pomona College Board of Trustees. Sam lives in San Francisco with his wife, Emily.

Read full bio →

Panel

How to leverage digital media to personalize patient engagement


Chris Kuenne

CEO, Rosemark capital

Chris has devoted his career to converting deep consumer insights into commercial value. He began his career in product management at Johnson & Johnson, where he rose quickly to run the $1B TYLENOL franchise, before starting his own marketing services business in 1998, called Rosetta. Chris and his team built Rosetta over the subsequent 13 years to be the largest privately held digital marketing agency in the world, before they sold it to the Publicis Groupe for a record price in 2011.

Since 2013, Chris has focused his energies on applying his commercialization skills to investing, teaching and writing a book on entrepreneurial founders. In 2014, Chris founded Rosemark Capital, a growth equity firm focused on investing in founding teams who have established product-market fit and are seeking capital and growth expertise to accelerate customer engagement, revenue and enterprise value. Rosemark specializes in the HealthTech, MarketingTech and FinTech sectors. Chris also teaches a very popular course at Princeton University on starting a high tech venture and is in the process of collaborating with one of his Princeton colleagues, John Danner, on a book devoted to understanding the role the personality of the founder plays in shaping the growth trajectory of the most successful enterprises.

Chris is a Board Member of Jiff, Sword Rowe, Princeton Day School, The New School University, The Burke Foundation and Broad Futures.

He graduated from Princeton University in 1985 with a B.A. in History and from the Harvard Business School with Honors in 1989. He lives in Princeton, NJ and Shelburne, VT with his wife Leslie and their three sons, Peter, William and Matthew.

Read full bio →

Panel

Are Digital Therapeutics the next unicorns?


Dr. Alan Levy

Chairman and Chief Executive Officer, Chrono Therapeutics

Dr. Levy brings more than 30 years of senior operational leadership and experience in the medical device industry. Prior to Chrono Therapeutics, he was the founding CEO of Incline Therapeutics that was acquired by The Medicines Company in January 2013 for up to $390 million.

Previously, he was the President and CEO of Northstar Neuroscience, a company developing innovative therapies for neurological diseases and disorders. Dr. Levy also served as the CEO of Heartstream, Inc. and was the President of Heart Technology, Inc.

Dr. Levy received his Ph.D. in Organic Chemistry from Purdue University, a B.S. in Chemistry from City University of New York, and holds an Honorary Doctor of Science from Purdue University. He serves as a board member of several public and private companies including Intuitive Surgical, Proteus Digital Health and Seattle BioMed.

Read full bio →


Mike Payne

Chief Commercial Officer and Head, Medical Affairs, Omada Health

Mike is a commercial leader who has worked with companies in almost every sector of health care. He believes that small companies with new ideas can change healthcare, but only if they work hand-in-hand with current leaders in the healthcare world. He is committed to making Omada into the leader of a new generation of health providers focused on evidence-based digital health programs for specific, complex diseases. Mike joined Omada from biotechnology leader Gilead Sciences, where he spent 6 years as Senior Director of Commercial Strategy, with experience in new product development, M&A, and marketing. Mike was previously with the healthcare practice at McKinsey & Company where he worked with healthcare clients in biotechnology/pharma, medical devices, health systems, and global health. Mike has an MBA from Stanford Business School as well as an MSc in Health Services Research from Stanford Medical School.



Rick Altinger

CEO, Glooko

Rick Altinger serves as Glooko’s first CEO, and brings over 15 years of industry experience in healthcare information technologies. While an executive at Intuit Health, Altinger helped launch the healthcare division’s provider services and drove Intuit’s acquisition of Medfusion in 2010. He also spearheaded Intuit Health’s growth as the leading supplier of patient-provider communication and patient portal services. His technical knowledge and expertise is central to Glooko’s diabetes healthcare platform and its goal of allowing anyone to monitor blood glucose levels regardless of meter, pump, CGM or mobile device type.


Who will be the 2015 Most Promising Healthtech Company?


Jack Young

General Partner, dRx Capital AG
Senior Director, Qualcomm Ventures

Jack heads up the Qualcomm Life Fund (QLF) at Qualcomm Ventures, which was ranked as one of the most active venture investors in digital health. He is also a fund manager at dRx Capital, a Novartis and Qualcomm joint investment company. His investment interests are focused on the intersection of healthcare products and services and digital/wireless technologies. Jack’s current digital health investments include: Airstrip, AliveCor, ClearCare, Doctor On Demand, goBalto, Telcare and Welltok. Prior investments include: Validity (acquired by Synaptics), and Fitbit (NYSE: FIT).

Prior to Qualcomm Ventures, Jack was EVP and US Country Manager at ZTE who helped establish the company’s US market presence. He was a sales and marketing executive at Nokia following the acquisition of Amber Networks where he was founding AVP of marketing. Early in his career, he held marketing and business development positions at 3Com, GDC, and Nortel. Jack earned a MSEE from University of Calgary and a MBA from McGill University.

Read full bio →


Renee C. Ryan

Vice President, Venture Investments

Renee Compton Ryan, Vice President, Venture Investments, joined Johnson & Johnson Innovation - JJDC, Inc. (JJDC) in 2011. She is based in Silicon Valley, California. Mrs. Ryan's background includes over 20 years of healthcare investment banking. Most recently, she ran the medical device investment banking effort at R.W. Baird & Co.

Previously, she lead the West Coast medical device group at Jefferies & Co. and was in the healthcare investment banking groups at Goldman Sachs and Credit Suisse. Mrs. Ryan received an MBA from Columbia Business School and a Bachelors degree from Georgetown University.



Casper de Clercq

Partner, Norwest Venture Partners

With over 30 years of experience, Casper is a veteran of the medical device and life sciences industry. He brings extensive operating knowledge to Norwest Venture Partners having led marketing and commercialization efforts for cardiovascular device, specialty pharmaceutical, and diagnostic companies. Casper focuses on mid-to-late-stage investments in medical devices, specialty pharmaceuticals, healthcare services, and healthcare IT. Along with his current board seats at Intersect ENT, iRhythm Technologies, and Simpirica Spine, Casper has invested in Misfit Wearables. He was previously on the board of Basis (acquired by Intel).



Tom Rodgers

Senior Vice President and Managing Director, McKesson Ventures

Tom Rodgers is the Senior Vice President and Managing Director leading McKesson Ventures. He spent more than a decade in health care venture capital, most recently leading strategic investing efforts for Cambia Health, and before that as a Partner with Advanced Technology Ventures.

Before his venture capital career, Rodgers had significant operating experience in the health care industry. He held various strategy and commercial roles at leading technology companies such as McKesson, Genentech, FitLinxx and The Wilkerson Group.

Rodgers holds an M.B.A. from the Wharton School and a B.A. from the University of Pennsylvania. He was an All-American rugby player and long ago the math team champion of New Hampshire.

Read full bio →

October 27, 2015

Workshops


Gale Richards

Partner, Bioquest

Gale Richards has built and developed senior leadership teams for fast-growing Healthcare Technology companies for over 25 years. As both a seasoned executive recruiter and a hands-on sales and marketing leader in the healthcare space, Gale knows what it takes to understand a company’s DNA and build the right teams to accomplish its mission.

As a partner at BioQuest since 2003, Gale has become an essential advisor to CEOs, board members and venture capitalists as they search for exactly the right talent for their senior leadership teams. Gale’s search experience is international and includes C-suite, board members and senior executives for every cross-functional role. Gale’s sectors of expertise include: Digital Health, Medical Devices and Diagnostics.

Prior to her career in Executive Search, Gale held executive level positions leading sales and marketing teams at Lumedx and Spacelabs Medical. During her 13-year tenure at Spacelabs, the company grew from a $25M private company to a $300M global leader in patient monitoring.

Gale is an active investor, as a member of Life Science Angels since 2008 and serves as a mentor for the Entrepreneurship Center at UCSF. Gale received her Bachelor of Science degree in Nursing from Texas Woman’s University and practiced as a registered nurse in emergency medicine.

Read full bio →


Michael O'Donnell

Partner, Morrison & Foerster LLP

Michael O'Donnell is a partner in the Palo Alto office of Morrison & Foerster LLP, specializing in corporate and securities law. He has more than 30 years of experience providing general corporate representation to biopharmaceutical and other life sciences companies. He offers particular expertise in venture capital financings, public offerings, mergers and acquisitions, strategic alliances, technology licensing, and corporate spin-out transactions. He represents numerous public and private biopharmaceutical, medical device, diagnostic, and instrumentation companies.



Robin Cisneros

National Director, Medical Technology Assessment and Products, The Permanente Federation

Robin Cisneros provides strategic direction and oversight of Kaiser Permanente’s new medical product and technology assessment and selection processes. For more than 25 years, Robin has been developing and leading the organization’s evidence-based, physician-led resources that assess, select, and purchase medical products and technology. This includes directing a complex, national network of clinical and business leaders, serving on several national KP initiatives, while aligning resources and clinical leadership to support large scale projects that deliver increasing value to patients and KP.



Wende Hutton

Managing Director, Canaan Partners

Healthcare investor Wende Hutton brings 20 years of experience to identifying, investing in and building companies that are changing the practice of medicine. She has facilitated bringing over a dozen medical devices and drugs to market, and currently sits on the boards of Aldea Pharmaceuticals, Butterfly Health, Chimerix (CMRX), Dermira, Labrys Biologics, ReVision Optics, Theraclone Sciences and Transcend Medical.

Wende joined Canaan in 2004, and her life sciences track record includes 6 IPOs and 4 acquisitions. She began her venture career at Mayfield Fund in 1993, where she worked closely with the founding teams of Heartstream (HPQ) and Northstar Neuroscience (NSTR). Earlier in her career, Wende held senior operational management positions at GenPharm International and Nellcor. Wende holds an AB in human biology from Stanford University and an MBA from Harvard Business School, where she was a Baker Scholar.

Read full bio →


Noah Lewis

Managing Director, GE Ventures

Noah Lewis specializes in MedTech and SaaS investing—with a focus on disease management business models integrating smart devices, software analytics and services. He founded GE Ventures portfolio operating practice and dedicates much of his time growing his previous investments including board positions at Ornim Medical, Veran Medical and Acutus Medical. Noah was named a "Top 10 Healthcare VC on Twitter", is quoted by industry journals including Medical Device & Diagnostics Industry and MedCityNews and is a frequent expert speaker at investment and globalization forums including the MedTech Investing Conference, the China, India & U.S. Life Science Markets Summit and the Private Equity & Venture Capital Summit. Prior to entering Venture Capital, he led strategic planning for the $10B GE Healthcare Systems division and started his career in the technology industry at IBM. Noah holds an MBA degree from MIT and a BS degree from Skidmore College. Noah lives in San Francisco and goes cycling in the Marin countryside any chance he gets.



Joel Krikston

Managing Director, Merck Global Health Innovation Fund

Joel Krikston is a Managing Director with Merck’s Global Health Innovation Fund, LLC (“GHI”). Joel is focused on identifying new investment opportunities in Health Information Technology and Technology Enabled Solutions with an emphasis on Decision Support, Accountable Care and Population Health. Joel is currently on the Board of MedCPU, Inc., is a Board Observer at Electrocore, LLC and is GHI’s representative to the New York Digital Health Accelerator.

Mr. Krikston has over 20 years of experience in healthcare innovation. Prior to joining Merck GHI in 2013, he was an Investment Principal at Johnson & Johnson Development Corporation, leading the group’s efforts in healthcare technology and diagnostics while also supporting medical devices and pharmaceuticals. He has previously served on the Boards of GetWellNetwork (acquired by Welsh Carson in 2012) and Imacor. During Mr. Krikston’s seven years with J&J, he served in a range of business development roles at both the corporate and operating company level focused on the identification, formation, development and launch of new businesses in emergent healthcare segments.

Prior to joining Johnson & Johnson, Joel spent over eight years as an investment banker, covering an array of healthcare clients and included experience at BNP Paribas, JPMorgan and ABN Amro. Joel has an MBA with honors from the Stern School of Business at NYU and completed his Bachelor’s degree in Finance and International Business at Fairfield University.

Read full bio →


Seth Frazier

Chief Transformation Officer, Evolent Health

Seth oversees Evolent Health’s client transformation practice. He most recently served as the Chief Transformation Officer for the Geisinger Health System prior to joining Evolent. His responsibilities included providing business leadership to large-scale innovation projects within the health system (e.g., Geisinger Accelerated Performance Program) and external consulting for Geisinger Ventures. Prior to Geisinger, Seth was Senior Vice President, Strategic Services for The Children’s Hospital of Philadelphia (CHOP). Seth led CHOP’s proton therapy development initiative, national contracting for tertiary services and strategic plan development and management. Before assuming the strategic services role, Seth had executive responsibilities for CHOP-affiliated Children’s Health Net, a pediatric managed care organization that developed and managed a globally capitated 100+ PCP network under contract with the dominant regional HMO. Seth came to CHOP after a 9-year consulting career with a large national health care firm. His practice areas included clinical resource management, managed care, service line strategy, hospital redesign and strategy.










Advance Registration
Sign up and get tickets
for only $750
$1,295 at the door